Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John W Yaxley

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
BJU International|July 28, 2017
Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesionsAnna J Yaxley, John W Yaxley, Isaac A Thangasamy, et al.
Prostate Cancer and Prostatic Diseases|March 23, 2024
Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?Matthew J Roberts, John W Yaxley, Johan Stranne, et al.
BJU International|September 16, 2016
Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 yearsJohn W Yaxley, Kevin Lah, Julian P Yaxley, et al.
The Medical Journal of Australia|October 13, 2020
Understanding the diagnosis of prostate cancerXuan Rui S Ong, Dominic Bagguley, John W Yaxley, et al.
Psycho-Oncology|October 30, 2019
A prospective study of psychological distress after prostate cancer surgeryStefano Occhipinti, Leah Zajdlewicz, Geoffrey D Coughlin, et al.
Advances in Urology|August 30, 2021
Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic ReviewStephen McGeorge, Michael Kwok, Andrew Jiang, et al.
Pathology|June 1, 2025
High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate samplingBrett Delahunt, Shulammite Johannsen, Lars Egevad, et al.
Asian Journal of Urology|February 5, 2024
The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[<sup>18</sup>F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer-related pathology: A single centre retrospective studyAnthony Franklin, Troy Gianduzzo, Boon Kua, et al.
The Journal of Urology|January 24, 2019
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with <sup>68</sup>Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node PathologyJohn W Yaxley, Sheliyan Raveenthiran, François-Xavier Nouhaud, et al.
European Urology Focus|August 25, 2021
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic ImplicationsArsalan Tariq, Amy E McCart Reed, Andrew Morton, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
BJU International|July 28, 2017
Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesionsAnna J Yaxley, John W Yaxley, Isaac A Thangasamy, et al.
Prostate Cancer and Prostatic Diseases|March 23, 2024
Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?Matthew J Roberts, John W Yaxley, Johan Stranne, et al.
BJU International|September 16, 2016
Long-term outcomes of high-dose-rate brachytherapy for intermediate- and high-risk prostate cancer with a median follow-up of 10 yearsJohn W Yaxley, Kevin Lah, Julian P Yaxley, et al.
The Medical Journal of Australia|October 13, 2020
Understanding the diagnosis of prostate cancerXuan Rui S Ong, Dominic Bagguley, John W Yaxley, et al.
Psycho-Oncology|October 30, 2019
A prospective study of psychological distress after prostate cancer surgeryStefano Occhipinti, Leah Zajdlewicz, Geoffrey D Coughlin, et al.
Advances in Urology|August 30, 2021
Dual-Tracer Positron-Emission Tomography Using Prostate-Specific Membrane Antigen and Fluorodeoxyglucose for Staging of Prostate Cancer: A Systematic ReviewStephen McGeorge, Michael Kwok, Andrew Jiang, et al.
Pathology|June 1, 2025
High proportion of clinically significant prostate adenocarcinomas in radical cystoprostatectomy specimens following complete prostate samplingBrett Delahunt, Shulammite Johannsen, Lars Egevad, et al.
Asian Journal of Urology|February 5, 2024
The risk of prostate cancer on incidental finding of an avid prostate uptake on 2-deoxy-2-[<sup>18</sup>F]fluoro-d-glucose positron emission tomography/computed tomography for non-prostate cancer-related pathology: A single centre retrospective studyAnthony Franklin, Troy Gianduzzo, Boon Kua, et al.
The Journal of Urology|January 24, 2019
Outcomes of Primary Lymph Node Staging of Intermediate and High Risk Prostate Cancer with <sup>68</sup>Ga-PSMA Positron Emission Tomography/Computerized Tomography Compared to Histological Correlation of Pelvic Lymph Node PathologyJohn W Yaxley, Sheliyan Raveenthiran, François-Xavier Nouhaud, et al.
European Urology Focus|August 25, 2021
Urothelial Carcinoma and Prostate-specific Membrane Antigen: Cellular, Imaging, and Prognostic ImplicationsArsalan Tariq, Amy E McCart Reed, Andrew Morton, et al.
Pageof 5